Interest in longevity, aging, or metabolic resilience
Patients should contact their GP, NHS 111, or healthcare provider if they experience any of the following: Severe or worsening itching that does not improve with simple measures or persists for more than 4872 hours Extensive redness, swelling, or warmth at the injection site, which may indicate cellulitis or another bacterial skin infection Development of a rash that spreads beyond the immediate injection site, particularly if accompanied by systemic symptoms Pain or tenderness that is disproportionate to the expected discomfort from a subcutaneous injection Discharge, pus, or bleeding from the injection site, suggesting possible infection or abscess formation Fever, chills, or malaise occurring in conjunction with injection site symptoms, which may indicate systemic infection or hypersensitivity Signs of a serious allergic reaction require immediate emergency attention
Gastrointestinal symptoms begin resolving for the majority of users
Subcutaneous injections: These use shorter, thinner needles (ranging from 0.5 to 5/8 inches), as they only need to reach the fatty layer beneath the skin
Are both agents currently available for clinical use
